Anticorps Recombinant de lapin anti-Pregnancy Zone Protein

Pregnancy Zone Protein Recombinant Antibody for WB, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

242114A6

N° de cat : 84605-4-PBS

Synonymes

PZP, pregnancy-zone protein, 242114A6

---

Galerie de données de validation

• 

  WB analysis of human plasma using 84605-4-RR (same clone as 84605-4-PBS)

  human plasma were subjected to SDS PAGE followed by western blot with 84605-4-RR (Pregnancy Zone Protein antibody) at dilution of 1:10000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 84605-4-PBS in a different storage buffer formulation.

• 

  Affinity and Kinetic Characterization of 84605-4-RR

  Biolayer interferometry (BLl) kinetic assays of 84605-4-RR against Human Pregnancy Zone Protein were performed. The affinity constant is below 1 pM.

---

Informations sur le produit

84605-4-PBS cible Pregnancy Zone Protein dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Recombinant
• Type: Anticorps
• Immunogène: Pregnancy Zone Protein Protéine recombinante Ag16471
• Nom complet: pregnancy-zone protein
• Masse moléculaire calculée: 1482 aa, 164 kDa
• Poids moléculaire observé: 180 kDa
• Numéro d’acquisition GenBank: BC111756
• Symbole du gène: Pregnancy Zone Protein
• Identification du gène (NCBI): 5858
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Protein A purfication
• Tampon de stockage: PBS only
• Conditions de stockage: Store at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Pregnancy Zone Protein (PZP) is an immunosuppressive protein that is expressed by the placenta. The PZP is a thiol ester-containing alpha macroglobulin protein that controls the proteolytic pathways during pregnancy and contributes to maintaining the immunologically privileged status of the fetus. Recently PZP over-expression has been described as a novel biomarker for predicting the prognosis of hepatocellular carcinoma and its high expression has been reported in solid tumors.

{{ptg:RelatedPrimaryAntibodies}}